JP2011502964A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502964A5
JP2011502964A5 JP2010531040A JP2010531040A JP2011502964A5 JP 2011502964 A5 JP2011502964 A5 JP 2011502964A5 JP 2010531040 A JP2010531040 A JP 2010531040A JP 2010531040 A JP2010531040 A JP 2010531040A JP 2011502964 A5 JP2011502964 A5 JP 2011502964A5
Authority
JP
Japan
Prior art keywords
subject
peptide
clip
treating
clip inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010531040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502964A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012078 external-priority patent/WO2009055005A2/en
Publication of JP2011502964A publication Critical patent/JP2011502964A/ja
Publication of JP2011502964A5 publication Critical patent/JP2011502964A5/ja
Pending legal-status Critical Current

Links

JP2010531040A 2007-10-23 2008-10-23 インバリアント鎖発現および／または異所性ｃｌｉｐ結合の競合的阻害剤 Pending JP2011502964A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15207P 2007-10-23 2007-10-23
US13715008P 2008-07-25 2008-07-25
US13596408P 2008-07-25 2008-07-25
PCT/US2008/012078 WO2009055005A2 (en) 2007-10-23 2008-10-23 Competitive inhibitors of invariant chain expression and/or ectopic clip binding

Publications (2)

Publication Number Publication Date
JP2011502964A JP2011502964A (ja) 2011-01-27
JP2011502964A5 true JP2011502964A5 (enExample) 2012-12-20

Family

ID=40580294

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010531040A Pending JP2011502964A (ja) 2007-10-23 2008-10-23 インバリアント鎖発現および／または異所性ｃｌｉｐ結合の競合的阻害剤

Country Status (6)

Country Link
US (4) US8957031B2 (enExample)
EP (1) EP2215108A4 (enExample)
JP (1) JP2011502964A (enExample)
AU (1) AU2008317374B2 (enExample)
CA (1) CA2703585A1 (enExample)
WO (1) WO2009055005A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175838A1 (en) * 2007-01-26 2009-07-09 Newell Rogers M Karen Methods of modulating immune function
CA2703585A1 (en) 2007-10-23 2009-04-30 The Regents Of The University Of Colorado Competitive inhibitors of invariant chain expression and/or ectopic clip binding
US20100166782A1 (en) * 2008-07-25 2010-07-01 Martha Karen Newell Clip inhibitors and methods of modulating immune function
WO2010011315A2 (en) * 2008-07-25 2010-01-28 Viral Genetics, Inc. Proteins for use in diagnosing and treating infection and disease
EP2323679A4 (en) * 2008-07-25 2012-08-22 Univ Colorado CLIP INHIBITORS AND METHODS FOR MODULATING IMMUNE FUNCTION
WO2012094495A2 (en) 2011-01-05 2012-07-12 The Texas A&M University System Clip modulation for the treatment of mucosal diseases
EP2694086A1 (en) * 2011-04-04 2014-02-12 The Texas A&M University System Mhc engagement and clip modulation for the treatment of disease
CA2862491A1 (en) 2011-12-01 2013-06-06 Scott & White Healthcare Methods and products for treating preeclampsia and modulating blood pressure
WO2015035414A1 (en) * 2013-09-09 2015-03-12 The Texas A&M University System Treating neurological disorders
GB2536650A (en) 2015-03-24 2016-09-28 Augmedics Ltd Method and system for combining video-based and optic-based augmented reality in a near eye display
US20170177802A1 (en) * 2015-12-17 2017-06-22 Allergy Solutions, Inc. Allergy Service Management Portal
SG10202111399YA (en) 2015-12-22 2021-11-29 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
GB201522667D0 (en) * 2015-12-22 2016-02-03 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
US20200268831A1 (en) * 2017-09-15 2020-08-27 The Texas A&M University System Methods for enhancing immunotherapy in the treatment of cancer
US12458411B2 (en) 2017-12-07 2025-11-04 Augmedics Ltd. Spinous process clamp
EP3517117A1 (en) * 2018-01-30 2019-07-31 Medizinische Universität Wien Medicament for prevention or treatment of rhinovirus infection
US11980507B2 (en) 2018-05-02 2024-05-14 Augmedics Ltd. Registration of a fiducial marker for an augmented reality system
US11766296B2 (en) 2018-11-26 2023-09-26 Augmedics Ltd. Tracking system for image-guided surgery
CN110033822B (zh) * 2019-03-29 2020-12-08 华中科技大学 蛋白质编码方法及蛋白质翻译后修饰位点预测方法及系统
TWI747121B (zh) * 2019-05-21 2021-11-21 大江生醫股份有限公司 茶樹葉的發酵物用於調控ＣＣＴ基因、Ｐｉｎｋ１基因、ＰＡＲＰ２基因、ＭＩＴＦ基因、ＵＮＧ基因、ＥＲＣＣ６基因、ＴＥＲＣ基因、ＣＤ４０基因、ＤＹＮＬＬ２基因、ＧＲＫ５基因、ＲＥＬＢ基因、ＴＮＦＳＦ１４基因、ＩＬ４Ｒ基因與ＲＥＬＡ基因的表現量及抗老化、美白、提升免疫力與降低脂肪累積之用途
CN110296833B (zh) * 2019-07-22 2020-08-18 齐鲁工业大学 一种面向液压缸综合测试台的软测量方法及系统
US11980506B2 (en) 2019-07-29 2024-05-14 Augmedics Ltd. Fiducial marker
US12178666B2 (en) 2019-07-29 2024-12-31 Augmedics Ltd. Fiducial marker
US11382712B2 (en) 2019-12-22 2022-07-12 Augmedics Ltd. Mirroring in image guided surgery
UY39226A (es) * 2020-05-22 2021-12-31 Alberto Riveros Carlos Sistema, método y uso de un medicamento para reducir la replicación viral en las vías respiratorias
US11389252B2 (en) 2020-06-15 2022-07-19 Augmedics Ltd. Rotating marker for image guided surgery
US12239385B2 (en) 2020-09-09 2025-03-04 Augmedics Ltd. Universal tool adapter
US20220293228A1 (en) * 2021-03-09 2022-09-15 Glenn Loomis Identification of Allergens in Food Products
US11896445B2 (en) 2021-07-07 2024-02-13 Augmedics Ltd. Iliac pin and adapter
US12150821B2 (en) 2021-07-29 2024-11-26 Augmedics Ltd. Rotating marker and adapter for image-guided surgery
WO2023021450A1 (en) 2021-08-18 2023-02-23 Augmedics Ltd. Stereoscopic display and digital loupe for augmented-reality near-eye display
WO2023203521A1 (en) 2022-04-21 2023-10-26 Augmedics Ltd. Systems and methods for medical image visualization
EP4587881A1 (en) 2022-09-13 2025-07-23 Augmedics Ltd. Augmented reality eyewear for image-guided medical intervention

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
WO1985003003A1 (fr) * 1984-01-12 1985-07-18 Volker Rusch Substance biologiquement active avec des proprietes hormonales, son procede de fabrication et utilisation d'histones a des fins medicales
WO1986005803A1 (fr) * 1985-03-30 1986-10-09 Marc Ballivet Procede d'obtention d'adn, arn, peptides, polypeptides ou proteines, par une technique de recombinaison d'adn
US7252829B1 (en) * 1998-06-17 2007-08-07 Idm Pharma, Inc. HLA binding peptides and their uses
ATE213162T1 (de) * 1992-03-13 2002-02-15 Terry R Beardsley Thymus-stammendes, immunverstärkendes agens zur therapeutischen verwendung in einem wirt mit einem angegriffenen immunsystem
US20050271676A1 (en) * 1993-03-05 2005-12-08 Epimmune Inc. Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
JP3814828B2 (ja) * 1993-10-19 2006-08-30 味の素株式会社 Ｈｉｖに対する免疫応答を誘導できるペプチド及び該ペプチドを含む抗ａｉｄｓ予防・治療剤
AU721463B2 (en) 1995-05-01 2000-07-06 Viral Genetics, Inc. Compositions and methods for detecting and treating acquired immunodeficiency syndrome
US7625565B2 (en) * 1995-05-01 2009-12-01 Viral Genetics, Inc. Antiviral compositions comprising lysine-rich histone fractions prepared by pepsin treatment of thymic cell nuclei
WO1997010335A1 (de) * 1995-09-14 1997-03-20 Universität Tübingen Rekombinantes polypeptid basierend auf der primärsequenz der invarianten kette mit mindestens einer primärsequenz von einem spezifischen t-zellepitop oder eines proteinderivats und dieses rekombinante polypeptid kodierende nukleinsäuren
WO1997025344A1 (en) * 1996-01-03 1997-07-17 The Australian National University Clip analogues and autoimmune disease
US20060008448A1 (en) * 1996-06-11 2006-01-12 Minzhen Xu Inhibition of li expression in mammalian cells
CA2270223A1 (en) 1996-10-28 1998-05-07 Carson B. Burgstiner (Deceased) Methods and compositions for dietary supplementation
AU6336398A (en) * 1997-02-24 1998-09-09 Johns Hopkins University, The Immunomodulatory polypeptides derived from the invariant chain of mhc class ii
MY131805A (en) * 1997-09-18 2007-09-28 Biogen Idec Inc Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis.
US6165493A (en) * 1997-10-22 2000-12-26 New York Blood Center, Inc. "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US20020182222A1 (en) * 1998-07-10 2002-12-05 Groot Anne De HIV vaccine candidate peptides
US6734192B1 (en) * 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections
US20020164685A1 (en) * 2000-01-31 2002-11-07 Rosen Craig A. Nucleic acids, proteins, and antibodies
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
CA2453880A1 (en) 2001-07-25 2003-02-06 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
CN1458165A (zh) 2002-01-26 2003-11-26 北海新升技术开发有限责任公司 一种多肽类物质及其制备方法和用途
FR2836483B1 (fr) * 2002-02-22 2006-09-15 Innate Pharma Procedes de production de lymphocytes gamma delta t
WO2003074567A2 (en) 2002-03-01 2003-09-12 Immunomedics, Inc. Internalizing anti-cd74 antibodies and methods of use
CN1694696A (zh) 2002-09-23 2005-11-09 牛津大学校委会 亚氨基糖衍生物在抑制离子通道活性中的应用
EP2364716A3 (en) 2002-11-08 2012-01-11 Genentech, Inc. Compositions and methods for the treatment of natural killer cell related diseases
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
WO2004110349A2 (en) * 2003-05-14 2004-12-23 Siga Technologies, Inc. Sars t cell epitopes and methods for identifying same
EP2292642A1 (en) 2003-06-10 2011-03-09 Opal Therapeutics Pty Ltd Immunomodulating compositions, uses therefor and processes for their production
WO2005007673A2 (en) * 2003-07-03 2005-01-27 Rush University Medical Center Immunogenic peptides
US8101714B2 (en) 2004-02-18 2012-01-24 The University Of Georgia Research Foundation, Inc. Teleost derived antimicrobial polypeptides
WO2006114799A1 (en) * 2005-04-27 2006-11-02 Universita' Degli Studi Di Roma 'tor Vergata' Synthetic peptides for the diagnosis and therapy of berillium granulomatous disease
US20080094510A1 (en) * 2005-08-05 2008-04-24 Samsung Electronics Co., Ltd. Apparatus for providing multiple screens and method of dynamically configuring multiple screens
WO2007091240A2 (en) 2006-02-06 2007-08-16 Immune System Key Ltd. Treatment of immunological diseases
US20080095798A1 (en) * 2006-10-18 2008-04-24 Robert Humphreys Ii-key enhanced vaccine potency
US20090291884A1 (en) 2006-11-02 2009-11-26 Michael Agadjanyan Proteins for use in diagnosing and treating infection and disease
US20090175838A1 (en) * 2007-01-26 2009-07-09 Newell Rogers M Karen Methods of modulating immune function
CA2703585A1 (en) 2007-10-23 2009-04-30 The Regents Of The University Of Colorado Competitive inhibitors of invariant chain expression and/or ectopic clip binding
US9073985B2 (en) * 2008-07-14 2015-07-07 The Regents Of The University Of Colorado, A Body Corporate Methods and products for treating proliferative diseases
WO2010011315A2 (en) * 2008-07-25 2010-01-28 Viral Genetics, Inc. Proteins for use in diagnosing and treating infection and disease
AU2009274508A1 (en) * 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Methods for treating viral disorders
US20100166782A1 (en) * 2008-07-25 2010-07-01 Martha Karen Newell Clip inhibitors and methods of modulating immune function
WO2012094495A2 (en) * 2011-01-05 2012-07-12 The Texas A&M University System Clip modulation for the treatment of mucosal diseases
EP2694086A1 (en) * 2011-04-04 2014-02-12 The Texas A&M University System Mhc engagement and clip modulation for the treatment of disease
CA2862491A1 (en) * 2011-12-01 2013-06-06 Scott & White Healthcare Methods and products for treating preeclampsia and modulating blood pressure

Similar Documents

Publication Publication Date Title
JP2011502964A5 (enExample)
JP2018171063A5 (enExample)
JP2014520120A5 (enExample)
JP2012525844A5 (enExample)
JP2004536077A5 (enExample)
JP2006506942A5 (enExample)
JP2004000251A5 (enExample)
JP2018515101A5 (enExample)
WO2003087768A3 (en) Targets for therapeutic intervention identified in the mitochondrial proteome
JP2002514205A (ja) 修飾型ポリアミドによる、主溝ｄｎａ結合タンパク質の阻害
AU2017311698B2 (en) Formulations for oral administration of active agents
JP2019533722A5 (enExample)
JP2010530238A5 (enExample)
JP2008530975A5 (enExample)
JP2006502702A5 (enExample)
JP2010536714A5 (enExample)
JP2007535910A5 (enExample)
WO2002020561A1 (en) Novel polypeptides and anti-hiv drugs containing the same
JP2008521795A5 (enExample)
JP2012518669A5 (enExample)
JP2008541776A5 (enExample)
JP2008517998A5 (enExample)
JP2003522185A5 (enExample)
JP2016539911A5 (enExample)
JP2019038772A5 (enExample)